
Michael Meulbroek
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Strategies to Minimize Time From HIV Acquisition to ART Initiation: The Barcelona Early-cART Program.
Journal: Open forum infectious diseases
Published: July 03, 2025
HCV infection, risk factors and PrEP use among HIV-negative MSM and TW at a community health centre.
HCV infection, risk factors and PrEP use among HIV-negative MSM and TW at a community health centre.
Journal: Journal of infection and public health
Published: June 16, 2025
Preserved central nervous system functioning after use of romidepsin as a latency-reversing agent in an HIV cure strategy.
Journal: AIDS (London, England)
Published: November 09, 2021
Epigenetic landscape in the kick-and-kill therapeutic vaccine BCN02 clinical trial is associated with antiretroviral treatment interruption (ATI) outcome.
Journal: EBioMedicine
Published: October 29, 2021
PrEP in the Context of Other HIV Risk Reduction Strategies Among Men Who Have Sex with Men: Results from the Flash! PrEP in Europe Survey.
Journal: Archives of sexual behavior
Published: July 05, 2021
Effects of integrase inhibitor-based antiretroviral therapy on brain outcomes according to time since acquisition of HIV-1 infection.
Journal: Scientific reports
Published: December 09, 2020
Falling HIV incidence in a community clinic cohort of men who have sex with men and transgender women in Barcelona, Spain.
Journal: International journal of STD & AIDS
Published: July 07, 2020
HIVconsv Vaccines and Romidepsin in Early-Treated HIV-1-Infected Individuals: Safety, Immunogenicity and Effect on the Viral Reservoir (Study BCN02).
Journal: Frontiers in immunology
Published: February 13, 2020
Corrigendum to 'Therapeutic vaccination refocuses T-cell responses towards conserved regions of HIV-1 in early treated individuals (BCN 01 study)' EClinicalMedicine 11 (2019) 65-80.
Journal: EClinicalMedicine
Published: January 21, 2020
Correction: Awareness, knowledge, use, willingness to use and need of Pre-Exposure Prophylaxis (PrEP) during World Gay Pride 2017.
Journal: PloS one
Published: April 30, 2019
Last Updated: 09/26/2026